NO20012825D0 - Aminosyrepartikler, fremgangsmåte for fremstilling og anvendelse av slike i pulvere for innhalering - Google Patents
Aminosyrepartikler, fremgangsmåte for fremstilling og anvendelse av slike i pulvere for innhaleringInfo
- Publication number
- NO20012825D0 NO20012825D0 NO20012825A NO20012825A NO20012825D0 NO 20012825 D0 NO20012825 D0 NO 20012825D0 NO 20012825 A NO20012825 A NO 20012825A NO 20012825 A NO20012825 A NO 20012825A NO 20012825 D0 NO20012825 D0 NO 20012825D0
- Authority
- NO
- Norway
- Prior art keywords
- amino acid
- particles
- inhalation
- powders
- preparation
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/007—Pulmonary tract; Aromatherapy
- A61K9/0073—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy
- A61K9/0075—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy for inhalation via a dry powder inhaler [DPI], e.g. comprising micronized drug mixed with lactose carrier particles
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
- A61K9/141—Intimate drug-carrier mixtures characterised by the carrier, e.g. ordered mixtures, adsorbates, solid solutions, eutectica, co-dried, co-solubilised, co-kneaded, co-milled, co-ground products, co-precipitates, co-evaporates, co-extrudates, co-melts; Drug nanoparticles with adsorbed surface modifiers
- A61K9/145—Intimate drug-carrier mixtures characterised by the carrier, e.g. ordered mixtures, adsorbates, solid solutions, eutectica, co-dried, co-solubilised, co-kneaded, co-milled, co-ground products, co-precipitates, co-evaporates, co-extrudates, co-melts; Drug nanoparticles with adsorbed surface modifiers with organic compounds
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/06—Antiasthmatics
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
- Y10T—TECHNICAL SUBJECTS COVERED BY FORMER US CLASSIFICATION
- Y10T428/00—Stock material or miscellaneous articles
- Y10T428/29—Coated or structually defined flake, particle, cell, strand, strand portion, rod, filament, macroscopic fiber or mass thereof
- Y10T428/2982—Particulate matter [e.g., sphere, flake, etc.]
Landscapes
- Health & Medical Sciences (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Veterinary Medicine (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Epidemiology (AREA)
- Pulmonology (AREA)
- Otolaryngology (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Medicinal Preparation (AREA)
- Transition And Organic Metals Composition Catalysts For Addition Polymerization (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Processes Of Treating Macromolecular Substances (AREA)
- Glanulating (AREA)
- Inorganic Compounds Of Heavy Metals (AREA)
- Carbon And Carbon Compounds (AREA)
- Glass Compositions (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GBGB9827145.5A GB9827145D0 (en) | 1998-12-09 | 1998-12-09 | Improvements in or relating to powders |
| PCT/GB1999/004156 WO2000033811A2 (en) | 1998-12-09 | 1999-12-09 | Improvements in or relating to powders |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| NO20012825L NO20012825L (no) | 2001-06-08 |
| NO20012825D0 true NO20012825D0 (no) | 2001-06-08 |
Family
ID=10843948
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| NO20012825A NO20012825D0 (no) | 1998-12-09 | 2001-06-08 | Aminosyrepartikler, fremgangsmåte for fremstilling og anvendelse av slike i pulvere for innhalering |
Country Status (24)
| Country | Link |
|---|---|
| US (1) | US6989155B1 (ja) |
| EP (1) | EP1137399B1 (ja) |
| JP (1) | JP4410942B2 (ja) |
| KR (1) | KR20010101138A (ja) |
| CN (1) | CN1334723A (ja) |
| AT (1) | ATE240093T1 (ja) |
| AU (1) | AU770461B2 (ja) |
| BR (1) | BR9916102A (ja) |
| CA (1) | CA2353448C (ja) |
| CZ (1) | CZ20012043A3 (ja) |
| DE (1) | DE69907951T2 (ja) |
| DK (1) | DK1137399T3 (ja) |
| EA (1) | EA004045B1 (ja) |
| ES (1) | ES2198973T3 (ja) |
| GB (1) | GB9827145D0 (ja) |
| HU (1) | HUP0104513A3 (ja) |
| MX (1) | MXPA01005584A (ja) |
| NO (1) | NO20012825D0 (ja) |
| NZ (1) | NZ511965A (ja) |
| PL (1) | PL348831A1 (ja) |
| PT (1) | PT1137399E (ja) |
| SK (1) | SK284775B6 (ja) |
| TR (1) | TR200101591T2 (ja) |
| WO (1) | WO2000033811A2 (ja) |
Families Citing this family (73)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US6582728B1 (en) | 1992-07-08 | 2003-06-24 | Inhale Therapeutic Systems, Inc. | Spray drying of macromolecules to produce inhaleable dry powders |
| US6858199B1 (en) | 2000-06-09 | 2005-02-22 | Advanced Inhalation Research, Inc. | High efficient delivery of a large therapeutic mass aerosol |
| DK2280020T3 (en) | 1999-06-29 | 2016-05-02 | Mannkind Corp | Pharmaceutical formulations comprising a peptide complexed with a diketopiperazine |
| US9006175B2 (en) | 1999-06-29 | 2015-04-14 | Mannkind Corporation | Potentiation of glucose elimination |
| US6586008B1 (en) * | 1999-08-25 | 2003-07-01 | Advanced Inhalation Research, Inc. | Use of simple amino acids to form porous particles during spray drying |
| JP2001151673A (ja) * | 1999-09-06 | 2001-06-05 | Nikken Chem Co Ltd | 吸入用粉末製剤の製造方法 |
| WO2002000197A1 (en) * | 2000-06-27 | 2002-01-03 | Vectura Limited | Method of making particles for use in a pharmaceutical composition |
| JP5698423B2 (ja) * | 2000-06-27 | 2015-04-08 | ベクトゥラ・リミテッド | 医薬組成物で使用するための粒子の製造法 |
| ES2689704T3 (es) * | 2000-11-30 | 2018-11-15 | Vectura Limited | Partículas para usar en una composición farmacéutica |
| PT2283817T (pt) | 2000-11-30 | 2016-08-22 | Vectura Ltd | Método de fabrico de partículas para utilização numa composição farmacêutica |
| DK2283818T3 (en) † | 2000-11-30 | 2017-10-16 | Vectura Ltd | Process for preparing particles for use in a pharmaceutical composition |
| JP2005520843A (ja) * | 2002-03-20 | 2005-07-14 | アドバンスト インハレーション リサーチ，インコーポレイテッド | 呼吸用持続性治療製剤 |
| US20110123574A1 (en) * | 2002-03-20 | 2011-05-26 | Alkermes, Inc. | Inhalable sustained therapeutic formulations |
| US7754242B2 (en) | 2002-03-20 | 2010-07-13 | Alkermes, Inc. | Inhalable sustained therapeutic formulations |
| ES2300568T3 (es) | 2002-03-20 | 2008-06-16 | Mannkind Corporation | Aparato de inhalacion. |
| EP1485068A2 (en) * | 2002-03-20 | 2004-12-15 | Advanced Inhalation Research, Inc. | hGH (HUMAN GROWTH HORMONE) FORMULATIONS FOR PULMONARY ADMINISTRATION |
| CA2522231A1 (en) * | 2003-04-14 | 2004-10-21 | Vectura Ltd | Pharmaceutical compositions comprising apomorphine for pulmonary inhalation |
| GB0327723D0 (en) * | 2003-09-15 | 2003-12-31 | Vectura Ltd | Pharmaceutical compositions |
| GB0321607D0 (en) * | 2003-09-15 | 2003-10-15 | Vectura Ltd | Manufacture of pharmaceutical compositions |
| CA2575692C (en) | 2004-08-20 | 2014-10-14 | Mannkind Corporation | Catalysis of diketopiperazine synthesis |
| BR122019022692B1 (pt) | 2004-08-23 | 2023-01-10 | Mannkind Corporation | Composição terapêutica em pó seco contendo dicetopiperazina, pelo menos um tipo de cátion e um agente biologicamente ativo |
| GB0425758D0 (en) * | 2004-11-23 | 2004-12-22 | Vectura Ltd | Preparation of pharmaceutical compositions |
| GB0426301D0 (en) * | 2004-11-30 | 2004-12-29 | Vectura Ltd | Pharmaceutical formulations |
| MX2007009656A (es) * | 2005-02-10 | 2007-11-07 | Glaxo Group Ltd | Proceso para elaborar lactosa utilizando tecnicas de clasificacion previa y formulaciones farmaceuticas formadas de la misma. |
| WO2007019229A1 (en) * | 2005-08-05 | 2007-02-15 | 3M Innovative Properties Company | Compositions exhibiting improved flowability |
| HUE028691T2 (en) | 2005-09-14 | 2016-12-28 | Mannkind Corp | A method for formulating a drug based on increasing the affinity of crystalline microparticle surfaces towards active ingredients |
| GB0525254D0 (en) | 2005-12-12 | 2006-01-18 | Jagotec Ag | Powder compositions for inhalation |
| EP1986679B1 (en) | 2006-02-22 | 2017-10-25 | MannKind Corporation | A method for improving the pharmaceutic properties of microparticles comprising diketopiperazine and an active agent |
| DE102006030164A1 (de) * | 2006-06-29 | 2008-01-03 | Boehringer Ingelheim Pharma Gmbh & Co. Kg | Inhalative Pulver |
| DE102006053375A1 (de) | 2006-11-10 | 2008-05-15 | Boehringer Ingelheim Pharma Gmbh & Co. Kg | Verfahren zur Mischung von Pulvern |
| US20090048155A1 (en) | 2007-08-15 | 2009-02-19 | Endacea, Inc. | Methods for preventing and treating tissue injury and sepsis associated with Yersinia pestis infection |
| US8785396B2 (en) * | 2007-10-24 | 2014-07-22 | Mannkind Corporation | Method and composition for treating migraines |
| EP2222676A4 (en) | 2007-12-21 | 2011-10-26 | Endacea Inc | A1-adenosine receptor antagonistic |
| US8485180B2 (en) | 2008-06-13 | 2013-07-16 | Mannkind Corporation | Dry powder drug delivery system |
| AR072114A1 (es) | 2008-06-13 | 2010-08-04 | Mannkind Corp | Un inhalador de polvo seco y sistema para suministro de farmacos |
| BRPI0914308B8 (pt) | 2008-06-20 | 2021-06-22 | Mannkind Corp | sistema de inalação |
| TWI614024B (zh) | 2008-08-11 | 2018-02-11 | 曼凱公司 | 超快起作用胰島素之用途 |
| US8314106B2 (en) | 2008-12-29 | 2012-11-20 | Mannkind Corporation | Substituted diketopiperazine analogs for use as drug delivery agents |
| PL2400950T3 (pl) | 2009-02-26 | 2019-12-31 | Glaxo Group Limited | Preparaty farmaceutyczne zawierające 4-{(1R)-2-[(6-{2-[(2,6-dichlorobenzylo)oksy]etoksy}heksylo)amino]-1-hydroksyetylo}-2-(hydroksymetylo)fenol |
| CA2754595C (en) | 2009-03-11 | 2017-06-27 | Mannkind Corporation | Apparatus, system and method for measuring resistance of an inhaler |
| GB0908129D0 (en) * | 2009-05-12 | 2009-06-24 | Innovata Ltd | Composition |
| KR101875969B1 (ko) | 2009-06-12 | 2018-07-06 | 맨카인드 코포레이션 | 한정된 비표면적을 갖는 디케토피페라진 마이크로입자 |
| EP2496295A1 (en) | 2009-11-03 | 2012-09-12 | MannKind Corporation | An apparatus and method for simulating inhalation efforts |
| GB0921075D0 (en) | 2009-12-01 | 2010-01-13 | Glaxo Group Ltd | Novel combination of the therapeutic agents |
| US9877967B2 (en) | 2010-01-26 | 2018-01-30 | Endacea, Inc. | Methods and pharmaceutical compositions for preventing and treating renal impairment |
| RU2571331C1 (ru) | 2010-06-21 | 2015-12-20 | Маннкайнд Корпорейшн | Системы и способы доставки сухих порошковых лекарств |
| WO2012030647A1 (en) * | 2010-08-30 | 2012-03-08 | Pulmatrix, Inc. | Treatment of cystic fibrosis using calcium lactate, leucine and sodium chloride in a respiraple dry powder |
| WO2012044736A1 (en) | 2010-09-29 | 2012-04-05 | Pulmatrix, Inc. | Monovalent metal cation dry powders for inhalation |
| KR101931392B1 (ko) * | 2010-11-09 | 2018-12-20 | 맨카인드 코포레이션 | 세로토닌 수용체 작용제 및 디케토피페라진을 포함하는 편두통 치료용 조성물 |
| AU2015249177B2 (en) * | 2010-11-09 | 2017-08-03 | Mannkind Corporation | Composition comprising a serotonin receptor agonist and a diketopiperazine for treating migraines |
| JP6133270B2 (ja) | 2011-04-01 | 2017-05-24 | マンカインド コーポレイション | 薬剤カートリッジのためのブリスター包装 |
| RU2448717C1 (ru) * | 2011-04-20 | 2012-04-27 | Закрытое акционерное общество Научно-производственное предприятие "Тринита" | Способ получения антикоагулянтно-фибринолитического средства на основе гепарина |
| WO2012174472A1 (en) | 2011-06-17 | 2012-12-20 | Mannkind Corporation | High capacity diketopiperazine microparticles |
| JP6018640B2 (ja) | 2011-10-24 | 2016-11-02 | マンカインド コーポレイション | 疼痛を緩和するのに有効な鎮痛組成物並びに当該組成物を含む乾燥粉末及び乾燥粉末薬剤輸送システム |
| SG11201500218VA (en) | 2012-07-12 | 2015-03-30 | Mannkind Corp | Dry powder drug delivery systems and methods |
| US10159644B2 (en) | 2012-10-26 | 2018-12-25 | Mannkind Corporation | Inhalable vaccine compositions and methods |
| WO2014106727A1 (en) | 2013-01-03 | 2014-07-10 | Vectura Limited | Inhaler and formulation |
| WO2014144895A1 (en) | 2013-03-15 | 2014-09-18 | Mannkind Corporation | Microcrystalline diketopiperazine compositions and methods |
| JP6473738B2 (ja) | 2013-04-01 | 2019-02-20 | パルマトリックス，インコーポレイテッド | チオトロピウム乾燥粉末 |
| AU2014290438B2 (en) | 2013-07-18 | 2019-11-07 | Mannkind Corporation | Heat-stable dry powder pharmaceutical compositions and methods |
| WO2015021064A1 (en) | 2013-08-05 | 2015-02-12 | Mannkind Corporation | Insufflation apparatus and methods |
| US10307464B2 (en) | 2014-03-28 | 2019-06-04 | Mannkind Corporation | Use of ultrarapid acting insulin |
| US10561806B2 (en) | 2014-10-02 | 2020-02-18 | Mannkind Corporation | Mouthpiece cover for an inhaler |
| CA2965759C (en) | 2014-10-31 | 2023-12-12 | Glaxosmithkline Intellectual Property Development Limited | Powdered polypeptides with decreased disulfide impurities comprising divalent cationic materials |
| ES2908479T3 (es) | 2015-08-26 | 2022-04-29 | Achillion Pharmaceuticals Inc | Compuestos para el tratamiento de trastornos inmunitarios e inflamatorios |
| AR106018A1 (es) | 2015-08-26 | 2017-12-06 | Achillion Pharmaceuticals Inc | Compuestos de arilo, heteroarilo y heterocíclicos para el tratamiento de trastornos médicos |
| RU2018145364A (ru) | 2016-06-27 | 2020-07-28 | Ачиллион Фармасьютикалс, Инк. | Хиназолиновые и индольные соединения для лечения медицинских нарушений |
| WO2018163085A1 (en) * | 2017-03-07 | 2018-09-13 | Philip Morris Products S.A. | Inhalable nicotine formulations, and methods of making and using thereof |
| US20190177588A1 (en) * | 2017-12-12 | 2019-06-13 | Xotramorphic LLC | Compositions, Methods, and Systems For Producing Flocculent Materials for Special Effects |
| WO2019191112A1 (en) | 2018-03-26 | 2019-10-03 | C4 Therapeutics, Inc. | Cereblon binders for the degradation of ikaros |
| CN110441198A (zh) * | 2018-05-03 | 2019-11-12 | 人福普克药业（武汉）有限公司 | 一种检测尼达尼布软胶囊中尼达尼布粒径的方法 |
| JP2021535112A (ja) | 2018-08-20 | 2021-12-16 | アキリオン ファーマシューティカルズ，インコーポレーテッド | 補体ｄ因子の医学的障害の治療のための医薬化合物 |
| EP3866773A4 (en) | 2018-10-16 | 2022-10-26 | Georgia State University Research Foundation, Inc. | CARBON MONOXIDE PRODRUGS FOR THE TREATMENT OF MEDICAL CONDITIONS |
Family Cites Families (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB9501841D0 (en) * | 1995-01-31 | 1995-03-22 | Co Ordinated Drug Dev | Improvements in and relating to carrier particles for use in dry powder inhalers |
| CA2218074C (en) | 1995-04-14 | 2002-10-08 | Mohammed Eljamal | Powdered pharmaceutical formulations having improved dispersibility |
| GB9515182D0 (en) * | 1995-07-24 | 1995-09-20 | Co Ordinated Drug Dev | Improvements in and relating to powders for use in dry powder inhalers |
| WO2001032144A1 (en) * | 1999-10-29 | 2001-05-10 | Inhale Therapeutic Systems, Inc. | Dry powder compositions having improved dispersivity |
-
1998
- 1998-12-09 GB GBGB9827145.5A patent/GB9827145D0/en not_active Ceased
-
1999
- 1999-12-09 BR BR9916102-8A patent/BR9916102A/pt not_active Application Discontinuation
- 1999-12-09 ES ES99958404T patent/ES2198973T3/es not_active Expired - Lifetime
- 1999-12-09 TR TR2001/01591T patent/TR200101591T2/xx unknown
- 1999-12-09 US US09/857,392 patent/US6989155B1/en not_active Expired - Fee Related
- 1999-12-09 JP JP2000586305A patent/JP4410942B2/ja not_active Expired - Fee Related
- 1999-12-09 WO PCT/GB1999/004156 patent/WO2000033811A2/en active IP Right Grant
- 1999-12-09 EP EP99958404A patent/EP1137399B1/en not_active Expired - Lifetime
- 1999-12-09 SK SK777-2001A patent/SK284775B6/sk unknown
- 1999-12-09 KR KR1020017007067A patent/KR20010101138A/ko not_active Application Discontinuation
- 1999-12-09 CN CN99816052A patent/CN1334723A/zh active Pending
- 1999-12-09 MX MXPA01005584A patent/MXPA01005584A/es unknown
- 1999-12-09 PL PL99348831A patent/PL348831A1/xx not_active IP Right Cessation
- 1999-12-09 NZ NZ511965A patent/NZ511965A/en not_active IP Right Cessation
- 1999-12-09 PT PT99958404T patent/PT1137399E/pt unknown
- 1999-12-09 DK DK99958404T patent/DK1137399T3/da active
- 1999-12-09 CZ CZ20012043A patent/CZ20012043A3/cs unknown
- 1999-12-09 AU AU15777/00A patent/AU770461B2/en not_active Ceased
- 1999-12-09 CA CA2353448A patent/CA2353448C/en not_active Expired - Fee Related
- 1999-12-09 HU HU0104513A patent/HUP0104513A3/hu unknown
- 1999-12-09 EA EA200100636A patent/EA004045B1/ru not_active IP Right Cessation
- 1999-12-09 DE DE69907951T patent/DE69907951T2/de not_active Expired - Lifetime
- 1999-12-09 AT AT99958404T patent/ATE240093T1/de not_active IP Right Cessation
-
2001
- 2001-06-08 NO NO20012825A patent/NO20012825D0/no not_active Application Discontinuation
Also Published As
| Publication number | Publication date |
|---|---|
| DE69907951D1 (de) | 2003-06-18 |
| JP4410942B2 (ja) | 2010-02-10 |
| ES2198973T3 (es) | 2004-02-01 |
| DE69907951T2 (de) | 2004-03-11 |
| AU1577700A (en) | 2000-06-26 |
| CA2353448C (en) | 2010-02-23 |
| NO20012825L (no) | 2001-06-08 |
| PL348831A1 (en) | 2002-06-17 |
| GB9827145D0 (en) | 1999-02-03 |
| ATE240093T1 (de) | 2003-05-15 |
| BR9916102A (pt) | 2001-09-04 |
| TR200101591T2 (tr) | 2001-11-21 |
| SK7772001A3 (en) | 2001-12-03 |
| NZ511965A (en) | 2003-09-26 |
| EA004045B1 (ru) | 2003-12-25 |
| HUP0104513A2 (hu) | 2002-03-28 |
| DK1137399T3 (da) | 2003-08-18 |
| CZ20012043A3 (cs) | 2001-12-12 |
| JP2002531487A (ja) | 2002-09-24 |
| CN1334723A (zh) | 2002-02-06 |
| SK284775B6 (sk) | 2005-11-03 |
| AU770461B2 (en) | 2004-02-19 |
| KR20010101138A (ko) | 2001-11-14 |
| EA200100636A1 (ru) | 2001-12-24 |
| EP1137399B1 (en) | 2003-05-14 |
| US6989155B1 (en) | 2006-01-24 |
| PT1137399E (pt) | 2003-09-30 |
| EP1137399A2 (en) | 2001-10-04 |
| HUP0104513A3 (en) | 2003-12-29 |
| CA2353448A1 (en) | 2000-06-15 |
| WO2000033811A2 (en) | 2000-06-15 |
| WO2000033811A3 (en) | 2000-10-12 |
| MXPA01005584A (es) | 2003-07-14 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| NO20012825L (no) | Aminosyrepartikler, fremgangsmåte for fremstilling og anvendelse av slike i pulvere for innhalering | |
| IL138770A0 (en) | Aerosol composition | |
| CA2432175A1 (en) | Storage stable powder compositions of interleukin-4 receptor | |
| AU2003258706A1 (en) | Powder inhaler | |
| DK1283036T3 (da) | Törpulver til inhalation | |
| MY132999A (en) | New formulation for inhalation | |
| HUP0300593A2 (hu) | Kemény pelletként kialakított gyógyászati készítmény száraz porral mżködż inhalátorhoz | |
| CA2183577A1 (en) | Methods and compositions for pulmonary delivery of insulin | |
| CA2211874A1 (en) | Carrier particles for use in dry powder inhalers | |
| WO2005025535A3 (en) | Methods for preparing pharmaceutical compositions | |
| IS5109A (is) | Ný lyfjablanda til innöndunar með eðlisþyngd í lausu sem er frá 0,28 til 0,38 g/ml, sem inniheldur formóteról | |
| NZ336592A (en) | Formulation for inhalation having a poured bulk density of from 0.28 to 0.38 g/ml comprising finely divided budesonide and a carrier | |
| PL355688A1 (en) | Antistatic powder coating compositions and their use | |
| AU6611898A (en) | Method for preparation of a therapeutic powder through coprecipitation of insulin and absorption enhancer | |
| AU1701402A (en) | Suspension of an epi-hne protein, process of preparation thereof, dry powder aerosol derived therefrom, pharmaceutical compositions containing said suspension or aerosol, and their uses | |
| AR007807A1 (es) | Polvo de aspartame para la aplicacion en mezclas de polvos y procedimiento para su preparacion | |
| MX2022015578A (es) | Composiciones en polvo de anatabina. | |
| HUP9902788A1 (hu) | Porlasztható makromolekuláris gyógyszerkészítmények, valamint előállításuk és alkalmazásuk |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| FC2A | Withdrawal, rejection or dismissal of laid open patent application |